GSK Touts Alli As Tip Of OTC Strength, Reaffirms Consumer Commitment

Sales exceeding $150 million in two weeks on retail shelves for OTC weight-loss drug alli figure prominently in GlaxoSmithKline's commitment to its consumer health care products division, senior executives say